Catalio, Tressa C.

HRN: 28-38-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2026
METRONIDAZOLE 500MG (TAB)
02/03/2026
02/05/2026
IV
500mg
Q8h
S/P CS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueReproductive Tract    Compliance to guidelines: